Nanovaccine Initiative Seminar
| Date/Time: | Monday, 26 Jan 2015 from 2:10 pm to 3:00 pm |
|---|---|
| Location: | 0020 Howe Hall |
| Cost: | Free |
| URL: | http://www.nanovaccine.iastate.edu/seminars/ |
| Contact: | Joel Severinghaus, |
| Phone: | 515-294-4902 |
| Channel: | Research |
| Categories: | Lectures |
| Actions: | Download iCal/vCal | Email Reminder |
Abstract
Dr. Howard E. Gendelman is the Margaret R. Larson Professor of Internal Medicine and Infectious Diseases, Chairman of the Department of Pharmacology and Experimental Neuroscience, and Director of the Center for Neurodegenerative Disorders at the University of Nebraska Medical Center. Dr. Gendelman is credited in unraveling how functional alterations in brain immunity induce metabolic changes and ultimately lead to neural cell damage for a broad range of infectious, metabolic and neurodegenerative disorders. These discoveries have had broad implications in developmental therapeutics aimed at preventing, slowing or reversing neural maladies. He is also credited for the demonstration that AIDS dementia is a reversible metabolic encephalopathy; a finding realized at the University of Nebraska Medical Center. His work has led to novel immunotherapy and nanomedicine strategies for Parkinson's and viral diseases currently being tested in early clinical trials as a result of intense translational investigations.